Hodgkin's lymphoma... a mediastinal "small mass
DOI:
https://doi.org/10.37615/retic.v1n3a9Keywords:
lymphoma, Hodgkin´s lymphoma, mediastinum.Abstract
We report the case of a 17 year-old male with Hodgkin’s lymphoma diagnosis who debuted with constitutional symptoms and the first finding was done by two dimensional echocardiography, which was later supplemented with chest tomography and histological study. Once the diagnosis was confirmed, chemotherapy and radiation therapy were started.
Downloads
Metrics
References
Gaillar, F. Mediastinal lymphoma. http://radiopaedia.org/articles/mediastinal-lymphoma
Glimelius I, Molin D, Amini RM, et al. Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB. Eur J Haematol 2003; 71: 327-333.
https://www.cancer.net/cancer-types/lymphoma-hodgkin
Gallamini A, Kostakoglu L. Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials? Blood 2012; 120: 4.913-4.920.
Bonfante V, Santoro A, Viviani S, et al. Early stage Hodgkin’s disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. Eur J Cancer 1992; 29A: 24-29.
Mauch P, Goodman R, Hellman S. The significance of mediastinal involvement in early stage Hodgkin’s disease. Cancer 1978; 42: 1.039-1.045.
Noordijk EM, Carde P, Dupouy N, et al. Combined-modality therapy for cli- nical stage I or II Hodgkin’s lymphoma: long-term results of the European Organization for Research and Treatment of Cancer H7 randomized contro- lled trials. J Clin Oncol 2006; 24: 3.128-3.135.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 Alma S. Arrioja Salazar, Luis Emiro Velazco C.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
